Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials Read the full story

Recent trends in preclinical partnering for the top pharma and biotech companies reviewed, over 2,000 deals analyzed – including summary of biopharma deal financials Read the full story

Antibodies are the subject of numerous partnering deals every year, here we provide a review of recent partnering trends activity. Read the full story

The article here analyses the recent partnering industry trends in the option and evaluation deal type areas. There are two major forms of deal terms that allow a party to secure rights to an asset subject to a future event Read the full story

The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation. Read the full story

The cost of prescription drugs is a perennial subject of heated debate Read the full story

A recent survey by Forbes has revealed the true cost of generating new drugs by looking at number of new product launches compared to R&D spend over the same period Read the full story

Partnering activity of the biopharma companies in Forbes Most Innovative Company list reviewed Read the full story

A recent study by Current Partnering identifies the most partnered therapeutic targets in recent years. Updated version of this article available here Top 15 most partnered therapeutic trends in pharma industry 2014 Read the full story

Pharmaceutical innovation has been recognized as essential for mid- to long-term success and even survival of science-based corporations such as pharmaceutical and biotechnology companies Read the full story